COMPARE GENERIKS INC
10KSB, EX-27, 2000-06-29
PHARMACEUTICAL PREPARATIONS
Previous: COMPARE GENERIKS INC, 10KSB, 2000-06-29
Next: NATIONSCREDIT GRANTOR TRUST 1996-1, 8-K, 2000-06-29



<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
This scheldule contains summary financial information extracted from the
financial statements and is qualified in its entirety by reference to such
financial statements.
</LEGEND>


<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          MAR-31-2000
<PERIOD-END>                               MAR-31-2000
<CASH>                                          53,075
<SECURITIES>                                         0
<RECEIVABLES>                                2,825,569
<ALLOWANCES>                                    10,000
<INVENTORY>                                  8,895,513
<CURRENT-ASSETS>                            12,083,366
<PP&E>                                          79,482
<DEPRECIATION>                                  36,879
<TOTAL-ASSETS>                              12,734,065
<CURRENT-LIABILITIES>                        8,257,145
<BONDS>                                              0
                                0
                                        590
<COMMON>                                           491
<OTHER-SE>                                   4,475,839
<TOTAL-LIABILITY-AND-EQUITY>                12,734,065
<SALES>                                     41,309,872
<TOTAL-REVENUES>                            41,309,872
<CGS>                                       36,549,384
<TOTAL-COSTS>                               36,549,384
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               2,129
<INCOME-PRETAX>                                458,700
<INCOME-TAX>                                   189,000
<INCOME-CONTINUING>                            269,700
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   269,700
<EPS-BASIC>                                        .04
<EPS-DILUTED>                                      .04




</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission